- Advertisement -

Halved risk for severe retinal disease in extremely premature infants

Credit: Photo by Elin Lindstrom Risk for a severe form of retinopathy of prematurity, which can cause...

New collaboration aims to boost vaccines manufacturing capability in South Africa

The Medicines Patent Pool (MPP) and the World Health Organization (WHO), Afrigen Biologics (PTY) Limited, the Biologicals and Vaccines Institute of Southern Africa (Biovac),...

2018 Biotechnology Research Review Market – Growth Opportunities Created By Covid19 Outbreak 2023 – PRnews Leader

The global market for cancer cell analysis should reach $10.8 billion by 2023 from $7.4 billion in 2018 at a compound annual growth rate...

Backbone Potential: Actuate’s Elraglusib Shows Promise vs. Pancreatic Cancer

Five years after Alex Trebek shared publicly his diagnosis of stage IV metastatic pancreatic cancer, therapies for the disease remain few, and limited to...

Biopharma, the Bull Market, and the Ballot

/* custom css */ .td_uid_1_5f787f5ba5f11_rand { vertical-align: baseline; } Leland Gershell, MD, PhD Managing Director and Senior Analyst BioPharmaceuticals, Oppenheimer /* custom css */ .td_uid_4_5f787f5ba855a_rand { vertical-align: baseline;...

Revolutionizing mRNA Concentration Measurement with Variable Pathlength Spectroscopy

View eBook Messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that carries the instructions from DNA to create specific proteins. The main applications...

Elix and University of Vienna Aim to Advance Drug Discovery Using...

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Argenx Expands Immunology Portfolio with $2.2B Buyout of Forte Biosciences

Argenx has agreed to acquire Forte Biosciences for $2.2 billion, the companies said, in a deal intended to expand the buyer’s immunology portfolio with...

Elix and University of Vienna Aim to Advance Drug Discovery Using AI

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Argenx Expands Immunology Portfolio with $2.2B Buyout of Forte Biosciences

Argenx has agreed to acquire Forte Biosciences for $2.2 billion, the companies said, in a deal intended to expand the buyer’s immunology portfolio with...

Parkinson’s Disease Medication Monitored with Fingertip Sweat Patch

Engineers and neuroscientists at the University of California (UC) San Diego have developed a soft, wearable fingertip patch that continuously tracks a Parkinson’s disease...

more new items

Elix and University of Vienna Aim to Advance Drug Discovery Using...

Tokyo-based Elix and the University of Vienna signed a joint research agreement aimed at advancing drug discovery using AI technologies. One of Elix’s business models...

Argenx Expands Immunology Portfolio with $2.2B Buyout of Forte Biosciences

Argenx has agreed to acquire Forte Biosciences for $2.2 billion, the companies said, in a deal intended to expand the buyer’s immunology portfolio with...

Parkinson’s Disease Medication Monitored with Fingertip Sweat Patch

Engineers and neuroscientists at the University of California (UC) San Diego have developed a soft, wearable fingertip patch that continuously tracks a Parkinson’s disease...